{"id":"W4405042663","doi":"10.1182/blood-2024-198408","title":"Mezigdomide (MEZI) Plus Dexamethasone (DEX) and Bortezomib (BORT) or Carfilzomib (CFZ) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from the CC-92480-MM-002 Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Université de Montréal; Hôpital Maisonneuve-Rosemont; University of Alberta","funders":"","keywords":"Carfilzomib; Bortezomib; Medicine; Dexamethasone; Multiple myeloma; Lenalidomide; Internal medicine; Refractory (planetary science); Oncology; Pomalidomide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001292087,0.0005112808,0.0009019983,0.0002465716,0.000127206,0.0007964961,0.0004789394,0.0004496753,0.001483318],"category_scores_gemma":[0.0009223489,0.0002880201,0.000952204,0.0004368917,0.0002701364,0.0005353906,0.0002962572,0.001399618,0.0002477303],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006618826,"about_ca_system_score_gemma":0.0005826887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001017867,"about_ca_topic_score_gemma":0.004569947,"domain_scores_codex":[0.9996492,0.0001567899,0.00003268045,0.00006302494,0.0000487295,0.00004959388],"domain_scores_gemma":[0.9995671,0.00009417172,0.0001788184,0.00003465002,0.00002627641,0.00009890321],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6930807,0.004340951,0.03459054,0.001975675,0.006620179,0.0002416018,0.0003446018,0.004079185,0.03374058,0.0002906716,0.007136207,0.2135592],"study_design_scores_gemma":[0.6198259,0.1954522,0.1444567,0.0003355473,0.009109234,0.001080609,0.0001686095,0.002312974,0.007898645,0.0005541004,0.01872513,0.00008026023],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9846475,0.01069836,0.0002989801,0.0004805133,0.00008271611,0.0004148661,0.001914974,0.00005055655,0.001411457],"genre_scores_gemma":[0.989221,0.004446369,0.0006790094,0.00050324,0.00009782649,0.0003149235,0.003879671,0.00001202829,0.000845883],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001483318,"threshold_uncertainty_score":0.006833315,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02674372181898471,"score_gpt":0.2772049587992465,"score_spread":0.2504612369802618,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}